These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19188038)

  • 1. Prediction of the stability of polymeric matrix tablets containing famotidine from the positron annihilation lifetime distributions of their physical mixtures.
    Szente V; Süvegh K; Marek T; Zelkó R
    J Pharm Biomed Anal; 2009 Apr; 49(3):711-4. PubMed ID: 19188038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of the drug release stability of different polymeric matrix tablets containing metronidazole.
    Szente V; Baska F; Zelkó R; Süvegh K
    J Pharm Biomed Anal; 2011 Mar; 54(4):730-4. PubMed ID: 21129883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tracking of the physical ageing of amorphous pharmaceutical polymeric excipients by positron annihilation spectroscopy.
    Zelkó R; Orbán A; Süvegh K
    J Pharm Biomed Anal; 2006 Feb; 40(2):249-54. PubMed ID: 16143484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the release characteristics of theophylline and the free volume of polyvinylpyrrolidone.
    Zelkó R; Süvegh K
    Eur J Pharm Sci; 2005 Mar; 24(4):351-4. PubMed ID: 15734301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization and validation of a dissolution test for famotidine tablets using flow injection analysis.
    Tzanavaras PD; Verdoukas A; Balloma T
    J Pharm Biomed Anal; 2006 May; 41(2):437-41. PubMed ID: 16413732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physical ageing of amorphous polymeric excipients III. The possible consequences of ageing].
    Zelkó R; Kiss D
    Acta Pharm Hung; 2006; 76(2):105-13. PubMed ID: 17094669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of dissolution media composition on drug release and in-vitro/in-vivo correlation for paracetamol matrix tablets prepared with novel carbomer polymers.
    Parojcić J; Ethurić Z; Jovanović M; Ibrić S; Jovanović D
    J Pharm Pharmacol; 2004 Jun; 56(6):735-41. PubMed ID: 15231038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay of amoxicillin sustained release from matrix tablets containing different proportions of Carbopol 971P NF.
    Tapia-Albarran M; Villafuerte-Robles L
    Int J Pharm; 2004 Apr; 273(1-2):121-7. PubMed ID: 15010136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of generic preparations of famotidine orally disintegrating tablets for use in unit-dose packages.
    Yamazaki N; Iizuka R; Miyazawa S; Wada Y; Shimokawa K; Ishii F
    Drug Discov Ther; 2012 Oct; 6(5):263-8. PubMed ID: 23229147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of cimetidine, famotidine, nizatidine, and ranitidine in tablets by capillary zone electrophoresis.
    Wu SM; Ho YH; Wu HL; Chen SH; Ko HS
    Electrophoresis; 2001 Aug; 22(13):2758-62. PubMed ID: 11545404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of cefmetazole sodium and famotidine.
    Lee DK; Wong CY; Wang DP; Chang LC; Wit KH
    Am J Health Syst Pharm; 1996 Feb; 53(4):432, 442. PubMed ID: 8673667
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of storage on microstructural changes of Carbopol polymers tracked by the combination of positron annihilation lifetime spectroscopy and FT-IR spectroscopy.
    Szabó B; Süvegh K; Zelkó R
    Int J Pharm; 2011 Sep; 416(1):160-3. PubMed ID: 21726620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spray-dried Amioca starch/Carbopol 974P mixtures as buccal bioadhesive carriers.
    Ameye D; Mus D; Foreman P; Remon JP
    Int J Pharm; 2005 Sep; 301(1-2):170-80. PubMed ID: 16019172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taste masking microspheres for orally disintegrating tablets.
    Xu J; Bovet LL; Zhao K
    Int J Pharm; 2008 Jul; 359(1-2):63-9. PubMed ID: 18455893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of ninhydrin to spectrophotometric determination of famotidine in drug formulations.
    Rahman N; Kashif M
    Farmaco; 2003 Oct; 58(10):1045-50. PubMed ID: 14505737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Design push-pull osmotic pump tablets of famotidine based on an expert system for the formulation design of osmotic pump of poor water-soluble drug].
    Zhang ZH; Jin J; Zhang HW; Xin W; Jia GB; Wu WF; Pan WS
    Yao Xue Xue Bao; 2011 Jan; 46(1):109-14. PubMed ID: 21465816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic spectrophotometric determination of famotidine in commercial dosage forms.
    Rahman N; Kashif M
    Anal Sci; 2003 Jun; 19(6):907-11. PubMed ID: 12834233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sodium bicarbonate on the properties of metronidazole floating matrix tablets.
    Gutiérrez-Sánchez PE; Hernández-León A; Villafuerte-Robles L
    Drug Dev Ind Pharm; 2008 Feb; 34(2):171-80. PubMed ID: 18302036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [UV spectrophotometric assay of famotidine in combination with picrolonic acid, picrolinate].
    Apostu M; Bibire N; Dorneanu V
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):422-5. PubMed ID: 16607813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Turbidimetric assay of famotidine].
    Apostu M; Dorneanu V; Bibire N; Vieriu M
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):460-4. PubMed ID: 17802962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.